Literature DB >> 8766863

Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta.

J Mühlhauser1, D Marzioni, M Morroni, M Vuckovic, C Crescimanno, M Castellucci.   

Abstract

In order to obtain an insight into morphogenetic processes such as angiogenesis, cell proliferation, and tissue remodeling we have studied the localization of basic fibroblast growth factor (bFGF) and heparan sulfate proteoglycan (HSPG) in the human placenta by immunohistochemistry. Positive reaction product for bFGF is found mainly in the villous trophoblastic covering and for HSPG in the villous basement membranes. A codistribution of the two molecules is detectable in first trimester placental tissue, in areas previously identified as being responsible for the growth of the villous tree, i.e., in the mesenchymal villi and the cytotrophoblastic cell islands and cell columns, both consisting of extravillous trophoblast. HSPG and bFGF are codistributed in the distal half of the villous stroma in the mesenchymal villi. In cell islands and cell columns, bFGF is detectable in the cytoplasm of the extravillous cytotrophoblastic cells, whereas HSPG is localized between the extravillous cytotrophoblastic cells and in their cytoplasm. HSPG-bFGF codistribution in term placenta is confined to the walls of fetal vessels and to some extravillous cytotrophoblastic cells in the basal plate. The codistribution of bFGF and HSPG in first trimester placental tissue suggests that these two molecules play a pivotal role in the morphogenetic processes mentioned above in early stages of gestation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766863     DOI: 10.1007/s004410050625

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

Review 1.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

2.  Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin.

Authors:  Marc Lecuit; D Michael Nelson; Steve D Smith; Huot Khun; Michel Huerre; Marie-Cécile Vacher-Lavenu; Jeffrey I Gordon; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

3.  Syndecan expressions in the human amnion and chorionic plate.

Authors:  T Lorenzi; A Turi; C Crescimanno; M Morroni; M Castellucci; G David; A L Tranquilli; D Marzioni
Journal:  Eur J Histochem       Date:  2010-10-27       Impact factor: 3.188

4.  Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line.

Authors:  Tomoka Takao; Kazuo Asanoma; Kiyoko Kato; Kotaro Fukushima; Ryosuke Tsunematsu; Toshio Hirakawa; Sueo Matsumura; Hiroyuki Seki; Satoru Takeda; Norio Wake
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

5.  High temperature requirement A1 and fibronectin: two possible players in placental tissue remodelling.

Authors:  G Tossetta; C Avellini; C Licini; S R Giannubilo; M Castellucci; D Marzioni
Journal:  Eur J Histochem       Date:  2016-11-21       Impact factor: 3.188

6.  Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies.

Authors:  Nikolett Lilla Szenasi; Eszter Toth; Andrea Balogh; Kata Juhasz; Katalin Karaszi; Oliver Ozohanics; Zsolt Gelencser; Peter Kiraly; Beata Hargitai; Laszlo Drahos; Petronella Hupuczi; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  PeerJ       Date:  2019-06-20       Impact factor: 2.984

7.  Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model.

Authors:  Xue Zhang; Xiaoshu Lv; Mengya Chen; Haixia Liu
Journal:  Int J Endocrinol       Date:  2020-02-17       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.